Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance

Massachusetts General Hospital · with The Leona M. and Harry B. Helmsley Charitable Trust · NCT07033208

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–75 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
25
US sites recruiting
1
Study start
June 3, 2025
Record last updated
October 2, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The goal of this research is to learn how a new device called the wireless thermal capsule (WTC) can collect thermal data to help see diseases that happen in the gastrointestinal (GI) tract, such as Crohn's Disease.

Being studied: Feasibility to obtain thermal variance measurements using a wireless thermal capsule

Conditions: Crohn Disease; Inflammatory Bowel Diseases; Healthy

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Participant is 18 -75 years old
  • Participant is considered healthy, with no known illnesses
  • Participant can follow fasting requirements
  • Participant can follow bowel prep instructions
  • Participant can provide informed consent

Exclusion Criteria

  • Participant is older than 75 years of age
  • Participant with current dysphagia or any swallowing disorder
  • Participant with any current condition believed to have an increased risk of capsule retention such as gastrointestinal strictures, intestinal tumors, bowel obstruction, incomplete colonoscopies or fistula
  • Participant with a diagnosis of gastroparesis or small bowel or large bowel dysmotility
  • Participant with a history of inflammatory bowel disease (IBD), intestinal Crohn's disease, chronic constipation, or rectal bleeding
  • Participant with clinical evidence of renal disease, including clinically significant laboratory abnormalities of renal function within the past 6 months
  • Participant with chronic usage of nonsteroidal anti-inflammatory drugs (NSAIDs)
  • Participants with a known contradiction to metoclopramide
  • Participants with a known contraindication to polyethylene glycol
  • Participant with currently suspected or diagnosed with hematochezia, melena, iron deficiency with or without anemia
  • Participant who has had intestinal surgery in the past
  • Participant with a history of congestive heart failure
  • Participant with Type I or Type II Diabetes
  • Participant has a cardiac pacemaker or other implanted electromedical device.
  • Participant expected to undergo MRI examination within 7 days after ingestion of the capsule.
  • Participant has participated in an investigational drug or device research study within 30 days of enrollment that may interfere with the subject's safety or ability to participate in this study
  • Participant with delayed gastric emptying
  • Participant who is pregnant, suspected pregnant, or is actively breast-feeding.

Recruiting US locations

  • Massachusetts General Hospital

    Boston, MA 02114

    Site contact: Anita Chung · 6177244515 · tearneylabtrials@partners.org

Study contacts (from the official record)

  • Anita Chung · 6177244515 · tearneylabtrials@partners.org
All healthy volunteers studies in Massachusetts →
Feasibility of a Wireless Thermal Capsule Endoscopy to Detect… (NCT07033208) | Bored Studies